Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Investor World Review.
Press releases published on April 26, 2025

XRP News: XenDex Community Rises in Thousands as XRP Investors Race to Secure Remaining Presale Tokens
SYDNEY, April 26, 2025 (GLOBE NEWSWIRE) -- The momentum behind XenDex is nothing short of electric. As the first all-in-one decentralized exchange (DEX) on the XRP Ledger offering AI-powered copy trading, non-custodial lending and borrowing, and cross- …

Mission Produce® inaugura empacadora de última generación en Guatemala para impulsar el suministro de aguacates durante todo el año
OXNARD, California, April 25, 2025 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” o "la Empresa”) un líder mundial en abastecimiento, producción y distribución de aguacates Hass frescos, anunció hoy la inauguración de su nueva …

A.I.S. Resources Closes Non-Brokered Private Placement
VANCOUVER, British Columbia, April 25, 2025 (GLOBE NEWSWIRE) -- A.I.S. Resources Limited (TSXV: AIS, OTC- PINK: AISSF) (“AIS” or the “Company”) announces the Company has closed its non-brokered private placement of 1,232,417 units (“Units”) at a price of $ …

ROSEN, NATIONALLY REGARDED INVESTOR RIGHTS COUNSEL, Encourages enCore Energy Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EU
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of enCore Energy Corp. (NASDAQ: EU) between March 28, 2024 and March 2, 2025, both dates inclusive (the “Class Period”), …

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Napco Security Technologies, Inc. Securities and Sets a Lead Plaintiff Deadline of June 24, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi …

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on April 23, 2025, the Board of …